Survival and functional quality of life after resection for hepatic carcinoid metastasis

Journal of Gastrointestinal Surgery

Volumn 8, Issue 6, 2004, Pages 653-659

  Knox, Clayton D ^a,b   Feurer, Irene D ^a   Wise, Paul E ^a   Lamps, Laura W ^a   Kelly Wright, J ^a   Chari, Ravi S ^a   Lee Gorden, D ^a   Wright Pinson, C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Carcinoid; liver; metastatic; neuroendocrine tumor; resection

Indexed keywords

TUMOR MARKER;

ADULT; AGED; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEPATIC CARCINOID METASTASIS; HUMAN; LIVER METASTASIS; LONGITUDINAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PROGNOSIS; QUALITATIVE ANALYSIS; QUALITY OF LIFE; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; SYNDROME; TUMOR VOLUME;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOID TUMOR; FEMALE; HUMANS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 4444245148     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2004.04.003     Document Type: Conference Paper

References (28)

1. Craig J.R., Peters R.L., Edmondson H.A. Carcinoid tumor. Hartman W.H. Atlas of Tumor Pathology, 2nd series, Fascicle 26. 1989;108-112 Armed Forces Institute of Pathology, Washington, DC
2. Oberndorfer S. Karzinoide Tumoren des dunndarms. Frankf Zschr Pathol. 1:1907;426-430
3. Staren E.D., Gould V.E., Warren W.H. Neuroendocrine carcinomas of the colon and rectum: A clinicopathologic evaluation. Surgery. 104:1988;1080-1089
4. Modlin I.M., Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 79:1997;813-829
5. Moertel C.G. Karnofsky Memorial Lecture: An odyssey in the land of small tumors. J Clin Oncol. 5:1987;1502-1522
6. Shebani K.O., Souba W.W., Finkelstein D.M., Stark P.C., Elgadi K.M., Tanabe K.K., Ott M.J. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 229:1999;815-823
7. Norheim I., Oberg K., Theodorsson-Norheim E., Lindgren P.G., Lundqvist G., Magnusson A., Wide L., Wilander E. Malignant carcinoid tumors. Ann Surg. 206:1987;115-125
8. Kloppel G., Heitz P.U., Capella C., Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg. 20:1996;132-141
9. Thompson G.B., Heerden J.A., Martin J.K. Jr., Schutt A.J., Istrup D.M., Carney J.A. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery. 98:1985;1054-1063
10. Soreide O., Berstad T., Bakka A., Schrumpf E., Hanssen L.E., Engh V., Bergan A., Flatmark A. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery. 111:1992;48-54
11. Yao K.A., Talamonti M.S., Nemcek A., Angelos P., Chrisman H., Skarda J., Benson A.B., Rao S., Joehl R.J. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 130:2001;677-682
12. McEntee G.P., Nagorney D.M., Kvols L.K., Moertel C.G., Grant C.S. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 108:1990;1091-1096
13. Wangberg B., Westberg G., Tylen U., Tisell L.E., Jansson S., Nilsson O., Johansson V., Schersten T., Ahlman H. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg. 20:1996;892-899
14. Grazi G.L., Cescon M., Pierangeli F., Ercolani G., Gardini A., Cavallari A., Mazziotti A. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology. 47:2000;481-486
15. Chamberlain R.S., Canes D., Brown K.T., Saltz L., Jarnigan W., Fong Y., Blumgart L.H. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 190:(4):2000;432-435
16. Gulec S.A., Mountcastle T.S., Frey D., Cundiff J.D., Mathews E., Anthony L., O'Leary J.P., Bourdreaux J.P. Cytoreductive surgery in patients with advanced-stage carcinoid tumors. Am Surg. 68:2002;667-771
17. Chen H., Hardacre J.M., Uzar A., Cameron J.L., Choti M.A. Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? J Am Coll Surg. 187:1998;88-92
18. Karnofsky D.A., Abelmann W.H., Craver L.F., Burchinal J.H. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1:1948;634-656
19. Miller C.A., Ellison C. Therapeutic alternatives in metastatic neuroendocrine tumors. Surg Oncol Clin North Am. 4:1998;868-879
20. Pascher A., Steinmuller T., Radke C., Hosten N., Wiedenmann B., Neuhaus P., Bechstein W.O. Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbecks Arch Surg. 385:2000;265-270
21. Foster J.H., Berman M.M. Solid liver tumors. Major problems in surgery. 1977;WB Saunders, Philadelphia. 236-243
22. Que F.G., Nagorney D.M., Batts K.P., Linz L.J., Kvols L.K. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 169:1995;36-42
23. Sarantou T., Bilchik A., Ramming K.P. Complications in hepatic cryosurgery. Semin Surg Oncol. 14:1998;156-162
24. Stewart G.J., Preketes A., Horton M., Ross W.B., Morris D.L. Hepatic cryotherapy: Double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology. 32:1995;215-219
25. Haddad F.F., Chapman W.C., Blair T.K., Wright J.K., Pinson C.W. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res. 75:1998;103-108
26. Siperstein A.E., Rogers S.J., Hansen P.D., Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery. 122:1997;1147-1155
27. Curley S.A., Izzo F., Delrio P., Ellis L.M., Granchi J.P., Vallone P., Fiore F., Pignata S., Daniele B., Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 230:1999;1-9
28. Brown K.T., Koh B.Y., Brody L.A., Getrajdman G.I., Susman J., Fong Y., Blumgart L.H. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Intervent Radiol. 10:1999;397-403